Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue PeerJ Année : 2016

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

1 School of Computing Science [Newcastle]
2 Institute of Cellular Medicine [Newcastle]
3 Facultad de Medicina - Instituto de Ciencias Biomédicas [Santiago, Chile]
4 Department of Clinical Science - Broegelmann Research Laboratory [Bergen, Norway]
5 Department of Immunology [Barcelona, Spain]
6 Department of Immunopathology [Amsterdam, The Netherlands]
7 Department of Infectious Diseases and Immunology [Utrecht, The Netherlands]
8 Faculty of Medicine and Health Sciences - Laboratory of Experimental Hematology [Wilrijk, Belgium]
9 U1064 Inserm - CRTI - Centre de Recherche en Transplantation et Immunologie
10 ITUN - Institut de transplantation urologie-néphrologie
11 Department of Surgery, Section of Experimental Surgery [Regensburg, Germany]
12 Institute of Cellular Therapeutics [Pittsburgh, PA, USA]
13 Division of Regenerative Medicine, Stem Cells and Gene Therapy [Milan, Italy]
14 Department of Laboratory Medicine [Nijmegen, the Netherlands]
15 Department of Nephrology [Leiden, The Netherlands]
16 Area of Cell Therapy [Pamplona, Spain]
17 Department of Immunohematology and Blood Transfusion [Leiden, The Netherlands]
18 Faculty of Medicine - Department of Immunology [Bursa, Turkey]
19 INEP - Institute for the Application of Nuclear Energy [Belgrade, Serbia]
20 Regenerative Medicine Institute [Galway, Ireland]
21 Thomas E. Starzl Transplantation Institute [Pittsburgh, PA, USA]
22 Immunology Division [Badalona, Spain]
23 CIBERDEM - Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas
24 Department of Cellular Biology, Physiology and Immunology [Barcelona, Spain]
Phillip Lord
  • Fonction : Auteur
  • PersonId : 1048463

Résumé

Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promiseforthetreatmentofautoimmunediseasesandforthepreventionofdestructive immune responses after transplantation. The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from differentstudies;thusconstitutingamajorhurdleforthedevelopmentofstandardised tolAPCtherapeuticproducts.HerewedescribeaninitiativebymembersofthetolAPC field to generate a minimum information model for tolAPC (MITAP), providing a reporting framework that will make differences and similarities between tolAPC productstransparent.Inthisway,MITAPconstitutesafirstbutimportantsteptowards the production of standardised and reproducible tolAPC for clinical application.
Fichier principal
Vignette du fichier
peerj-04-2300.pdf (516.6 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-02150722 , version 1 (07-06-2019)

Identifiants

Citer

Phillip Lord, Rachel Spiering, Juan C Aguillon, Amy E Anderson, Silke Appel, et al.. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies. PeerJ, 2016, 4, pp.e2300. ⟨10.7717/peerj.2300⟩. ⟨inserm-02150722⟩
51 Consultations
64 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More